Literature DB >> 22802010

Ultrasonography is a potent tool for the prediction of progressive joint destruction during clinical remission of rheumatoid arthritis.

Ryusuke Yoshimi1, Maasa Hama, Kaoru Takase, Atsushi Ihata, Daiga Kishimoto, Kayo Terauchi, Reikou Watanabe, Takeaki Uehara, Sei Samukawa, Atsuhisa Ueda, Mitsuhiro Takeno, Yoshiaki Ishigatsubo.   

Abstract

OBJECTIVES: Although "clinical remission" has been a realistic goal of treatment in rheumatoid arthritis (RA), there is evidence that subclinical synovitis is associated with ongoing structural damage even after clinical remission is achieved. In the study reported here, we assessed whether ultrasonography (US) can predict progressive joint destruction during clinical remission of RA.
METHODS: Thirty-one patients with RA in clinical remission based on the disease activity score in 28 joints were recruited for this study. Bilateral wrists and all of the metacarpophalangeal and proximal interphalangeal (PIP) joints were examined by power Doppler (PD) ultrasonography (US), and the PD signals were scored semiquantitatively in each joint. The total PD score was calculated as the sum of individual scores for each joint.
RESULTS: Among 22 RA patients who maintained clinical remission during the 2-year follow-up period, seven showed radiographic progression. Radiographic progression was strongly associated with total PD score at entry, with all patients showing radiographic progression having a total PD score of ≥ 2 at entry and none of the patients with a total PD score of ≤ 1 showing any radiographic progression. There was no significant association of therapeutic agents with progressing or non-progressing cases.
CONCLUSIONS: PD-US detects synovitis causing joint destruction even when the patient is in clinical remission. Thus, remission visible on US is essential to reach "true remission" of RA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802010     DOI: 10.1007/s10165-012-0690-1

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  18 in total

1.  Prediction of recurrence and remission using superb microvascular imaging in rheumatoid arthritis.

Authors:  Hidemasa Matsuo; Akari Imamura; Madoka Shimizu; Maiko Inagaki; Yuko Tsuji; Shuichiro Nakabo; Motomu Hashimoto; Hiromu Ito; Shiro Tanaka; Tsuneyo Mimori; Yasutomo Fujii
Journal:  J Med Ultrason (2001)       Date:  2019-09-25       Impact factor: 1.314

2.  Ultrasound-detected activity in rheumatoid arthritis on methotrexate therapy: Which joints and tendons should be assessed to predict unstable remission?

Authors:  Iustina Janta; Lara Valor; Inmaculada De la Torre; Lina Martínez-Estupiñán; Juan Carlos Nieto; Juan Gabriel Ovalles-Bonilla; Julia Martínez-Barrio; Natalia Bello; Michelle Hinojosa; María Montoro; Carlos Manuel González; Javier López-Longo; Indalecio Monteagudo; Luis Carreño; Esperanza Naredo
Journal:  Rheumatol Int       Date:  2015-12-28       Impact factor: 2.631

3.  Do patients with juvenile idiopathic arthritis in remission exhibit active synovitis on joint ultrasound?

Authors:  Vanessa Bugni Miotto e Silva; Carolina de Freitas Tavares da Silva; Sônia de Aguiar Vilela Mitraud; Rita Nely Vilar Furtado; Maria Odete Esteves Hilário; Jamil Natour; Maria Teresa Terreri
Journal:  Rheumatol Int       Date:  2013-12-08       Impact factor: 2.631

Review 4.  MRI of synovitis and joint fluid.

Authors:  Christopher J Burke; Hamza Alizai; Luis S Beltran; Ravinder R Regatte
Journal:  J Magn Reson Imaging       Date:  2019-01-08       Impact factor: 4.813

5.  Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis.

Authors:  Nicolò Girolimetto; Pierluigi Macchioni; Ilaria Tinazzi; Luisa Costa; Rosario Peluso; Marco Tasso; Vittoria Bascherini; Olga Addimanda; Antonio Marchetta; Niccolò Possemato; Carlo Salvarani; Dennis McGonagle; Raffaele Scarpa; Francesco Caso
Journal:  Clin Rheumatol       Date:  2019-07-13       Impact factor: 2.980

6.  [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.

Authors:  Yukio Yonemoto; Koichi Okamura; Kimihiko Takeuchi; Tetsuya Kaneko; Tsutomu Kobayashi; Chisa Okura; Yoshito Tsushima; Kenji Takagishi
Journal:  Rheumatol Int       Date:  2015-08-02       Impact factor: 2.631

7.  Treat-to-target strategies aiming at additional ultrasound remission is associated with better control of disease activity and less flare in rheumatoid arthritis.

Authors:  Yan Geng; Liujun Wang; Xiaohui Zhang; Lanlan Ji; Xuerong Deng; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2020-06-08       Impact factor: 2.980

8.  Comparison of prevalence of synovitis by ultrasound assessment in subjects exposed or not to self-reported physical overexertion: the Monday's synovitis.

Authors:  C A Guillén Astete; A Boteanu; A Zea Mendoza
Journal:  ScientificWorldJournal       Date:  2014-11-06

9.  Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score.

Authors:  Takahito Suto; Koichi Okamura; Yukio Yonemoto; Chisa Okura; Yoshito Tsushima; Kenji Takagishi
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission.

Authors:  Stefano Alivernini; Giusy Peluso; Anna Laura Fedele; Barbara Tolusso; Elisa Gremese; Gianfranco Ferraccioli
Journal:  Arthritis Res Ther       Date:  2016-02-03       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.